HB Biotech
New York, US · Founded 2022
Founders & leadership
TS
Tomer SeifanChief Executive Officer
Reported raises · per SEC filings
Form D private placements▶$7.8MraisedDec 2022 · 17 investors · OtherRule 506(b)
▶$7.8MraisedDec 2022 · 17 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tomer SeifanExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $7.8M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.